Based on the measurements of operating efficiency obtained from ResMed's historical financial statements, ResMed Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, ResMed's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 425.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 147.7 M. Key indicators impacting ResMed's financial strength include:
The essential information of the day-to-day investment outlook for ResMed includes many different criteria found on its balance sheet. An individual investor should monitor ResMed's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in ResMed.
Please note, the presentation of ResMed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ResMed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ResMed's management manipulating its earnings.
ResMed Stock Summary
ResMed competes with Teleflex Incorporated, West Pharmaceutical, Alcon AG, ICU Medical, and Cooper Companies,. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 8160 people.
Comparative valuation techniques use various fundamental indicators to help in determining ResMed's current stock value. Our valuation model uses many indicators to compare ResMed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ResMed competition to find correlations between indicators driving ResMed's intrinsic value. More Info.
ResMed Inc is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ResMed Inc is roughly 1.85 . At present, ResMed's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value ResMed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
ResMed Inc Systematic Risk
ResMed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ResMed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on ResMed Inc correlated with the market. If Beta is less than 0 ResMed generally moves in the opposite direction as compared to the market. If ResMed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ResMed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ResMed is generally in the same direction as the market. If Beta > 1 ResMed moves generally in the same direction as, but more than the movement of the benchmark.
ResMed Thematic Clasifications
ResMed Inc is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
Today, most investors in ResMed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ResMed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ResMed growth as a starting point in their analysis.
Price Earnings To Growth Ratio
2.43
At present, ResMed's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
ResMed March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ResMed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ResMed Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of ResMed Inc based on widely used predictive technical indicators. In general, we focus on analyzing ResMed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ResMed's daily price indicators and compare them against related drivers.
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.